Bellicum Pharmaceuticals

Bellicum Pharmaceuticals, Inc. is focused primarily on the development of next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer. Bellicum’s novel approach is to utilize precise knowledge of the signaling pathways that regulate the immune response to target specific factors that can influence the potency and duration of this response.

Tom Farrell

(713) 341-6472
Visit Bellicum Pharmaceuticals